2020 ASCO Virtual Direct™ Highlights

 

GU
09:56

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced RCC: Does Extended Follow-up Continue to Support Pembrolizumab + Axitinib as a SoC for Patients With Previously Untreated Disease?

FEATURING Russell Pachynski
  • 44 views
  • July 15, 2020
10:56

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced RCC: Does Nivolumab Monotherapy Represent an Alternative Frontline Approach in Treatment-naive Patients?

FEATURING Russell Pachynski
  • 93 views
  • July 15, 2020
10:41

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced mUC: Is There a DFS Benefit to Adjuvant CPI in MIUC?

FEATURING Russell Pachynski
  • 25 views
  • July 15, 2020
06:35

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on mUC: Can We Consider Recently FDA Approved Avelumab Maintenance a New 1st-line SoC? Is Switch Maintenance Checkpoint Inhibition Preferred Over a Treatment Break Followed by 2nd Line?

FEATURING Russell Pachynski
  • 53 views
  • July 15, 2020